GUIDANCE ON ASPECTS OF CLEANING ... - …

confidential 1 revision september 2016 active pharmaceutical ingredients committee (apic) guidance on aspects of cleaning validation in …

  Pharmaceutical, Active, Ingredients, Committees, Apic, Active pharmaceutical ingredients committee

GUIDELINE for QUALIFICATION & MANAGEMENT …

active pharmaceutical ingredients committee (apic) guideline for qualification & management of contract quality control laboratories 10 january 2012

  Management, Contract

Quality Management System - apic.cefic.org

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005

  System, Pharmaceutical, Management, Quality, Quality management system

“How to do” Document

The explanatory notes in this guide are the views of The Active Pharmaceutical Ingredients Commit- tee (APIC) and not necessarily those of the European Commission or WHO. This document does not intend to provide an exhaustive list of how to comply with the require-

  Notes, Pharmaceutical, Document, Explanatory notes, Explanatory, How to do document

ACTIVE PHARMACEUTICAL INGREDIENTS …

APIC_eCTD How to Do Page 4 INTRODUCTION eCTD is a topic of increasing interest in the pharmaceutical environment. In the past, the main focus for regulatory authorities was eCTD submissions sent via MAAs.

  Pharmaceutical, Active, Ingredients, Active pharmaceutical ingredients, Apic

ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE …

- Stefaan Van De Velde, Ajinomoto Bio-Pharma Services, Belgium A revision of the guidance document was done in 2016 to bring it in line with the European Medicines Agency Guidance on use of Health Based data on setting health-based exposure limits for determining safe threshold values for the cleaning1. The main changes were

  Pharmaceutical, Active, Ingredients, Committees, Active pharmaceutical ingredients committee, Pharma

Registered Starting Material Auditing Guide - …

AIDE MEMOIRE FOR REGISTERED STARTING MATERIAL AUDITS 1) APIC Guide for Auditing Registered Starting Material Manufacturers * tbi = to be implemented Page 2 / 23 ** Procedure, SOP, OI, memo, notes (personal), Q-manual

  Auditing

Guidance on Handling of Insoluble Matter and …

APIC Guidance on Insoluble Matter and Foreign Particles in APIs Page 3 of 19 Table of contents 1. Acknowledgements 2. Introduction and Purpose

Quality Agreement for Laboratories Guideline Templates

A Quality Agreement under the scope of this guideline is a legally binding agreement that is mutually negotiated and concluded between (the Quality Departments of) the service requestor and the Quality responsible at the service providing laboratory.

  Laboratory, Agreement

Practical risk-based guide for managing data integrity

Assign GxP data to a specific category based on a . severity assessment (refer to section 4.1) Create a . profile. of each . system. based on the way GxP data is handled by that system (e.g. data generation, storage, processing, transfer or a combination thereof) and assign a category to the system based on its profile; (refer to section 4.2)

  Based, Managing

Q7 Q&A - good manufacturing practice for active ...

active pharmaceutical ingredients– questions and answers . Step 5 . Transmission to CHMP . 20 July 2015 . Release for information . 4 August 2015 : Implementation . 4 February 2016 : ICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients

  Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Active pharmaceutical, Manufacturing practice for active pharmaceutical ingredients

DEFINITION OF ACTIVE PHARMACEUTICAL INGREDIENT

"active pharmaceutical ingredient (API) A substance used in a finished pharmaceutical product (FPP), intended to furnish pharmacological activity or to otherwise have direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to have direct effect in restoring,

  Pharmaceutical, Active, Active pharmaceutical

Q 7 Good Manufacturing Practice for Active Pharmaceutical ...

GOOD MANUFACTURING PRACTICE FOR ACTIVE PHARMACEUTICAL INGREDIENTS TABLE OF CONTENTS Section Title 1 Introduction 1.1 Objective 1.2 Regulatory Applicability 1.3 Scope 2 Quality Management 2.1 Principles 2.2 Responsibilities of the Quality Unit(s) 2.3 Responsibility for Production Activities 2.4 Internal Audits (Self-Inspection) ...

  Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Manufacturing practice for active pharmaceutical, Manufacturing practice for active pharmaceutical ingredients

Annex 2 W HO good manufacturing practices for active ...

W HO good manufacturing practices for active pharmaceutical ingredients 1. Introduction 1.1 Objective 1.2 Regulatory applicability 1.3 Scope 2. Quality management 2.1 Principles 2.2 Responsibilities of the quality unit(s) 2.3 Responsibility for production activities 2.4 Internal audits (self-inspection) 2.5 Product quality review 3. Personnel

  Pharmaceutical, Active, Active pharmaceutical

GUIDANCE ON ASPECTS OF CLEANING VALIDATION IN …

The subject of cleaning validation in active pharmaceutical ingredient manufacturing plants has continued to receive a large amount of attention from regulators, companies and customers alike. The integration of Cleaning Validation within an effective Quality System supported by Quality Risk Management Processes should give assurance that API ...

  Pharmaceutical, Active, Active pharmaceutical

Polymorphism—A Critical Consideration in Pharmaceutical ...

• Pharmaceutical solids may be crystals, crystal solvates or hydrates, crystal desolvated solvates or dehydrated hydrates, or amorphous solids ... active sites exposed have a tendency to either reabsorb water or to bind to other available moieties. Over drying

  Pharmaceutical, Active

ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE …

transferred back in the process to active pharmaceutical ingredient manufacturers without consideration for the different processes that take place at this stage. For example, higher limits may be acceptable in chemical production compared to pharmaceutical production because the carry-over risk is much lower for technical and

  Pharmaceutical, Active, Ingredients, Committees, Active pharmaceutical, Active pharmaceutical ingredients committee